Research Interests

His research involves discovering and implementing novel biomarkers of disease using mass spectrometry techniques, with particular interest in the discovery of biomarkers (proteins, metabolites and lipids) using state-of-the-art analytical techniques in combination with novel data interrogation techniques. From these projects the group are establishing targeted assays for biomarkers and working with pathology colleagues to validate and achieve clinical accreditation for assays.

Professor Jones is also Co-director of Institute for Precision Health (IPH) which helps coalesce precision medicine activity across the University and NHS. All this work helps to underpin the implementation of precision medicine by finding novel tools to personalise diagnosis and treatment in modern medicine.

He plays an active role in the NIHR Biomedical Research Centre which allows this research to be translated into clinical use.

His primary area of research is cardiovascular (BHF and EU FP7) and cancer biomarkers (CRUK BLF and WRCF) but work more recently has focussed on COVID-19, helping to develop a mass spectrometry (MS) assay for the SARS-CoV-2 virus which can be implemented as an alternative to RT-PCR.

Professor Jones is also very interested in developing cutting edge MS techniques for the analysis of biological molecules.